{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:28:29Z","timestamp":1793053709482,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010711","name":"Cancer Foundation Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004012","name":"Jane and Aatos Erkko Fundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005424","name":"Southwest Finland Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005424","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007797","name":"University of Helsinki","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007797","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.euo.2026.03.014","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T21:19:34Z","timestamp":1778188774000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["PI-RADS v2 and Adverse Prostate Cancer Outcomes: A Cross-cohort Replication Study Across Three Centers"],"prefix":"10.1016","author":[{"given":"Tolou","family":"Shadbahr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juho","family":"Pylv\u00e4l\u00e4inen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juho","family":"Eineluoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg","family":"Kerro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Kentt\u00e4mies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugen","family":"Czeizler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teemu J.","family":"Murtola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyon-Jung","family":"Kim-Ollila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Puech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnauld","family":"Villers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaakko","family":"Peltonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Nykter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuomas","family":"Mirtti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7016-7354","authenticated-orcid":false,"given":"Teemu D.","family":"Laajala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti S.","family":"Rannikko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2026.03.014_b0005","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.eururo.2013.12.062","article-title":"Overdiagnosis and overtreatment of prostate cancer","volume":"65","author":"Loeb","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.03.014_b0010","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s00330-011-2377-y","article-title":"ESUR prostate MR guidelines 2012","volume":"22","author":"Barentsz","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1016\/j.euo.2026.03.014_b0015","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","article-title":"PI-RADS Prostate Imaging - reporting and data system: 2015, version 2","volume":"69","author":"Weinreb","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.03.014_b0020","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41585-020-0356-2","article-title":"Rethinking prostate cancer screening: could MRI be an alternative screening test?","volume":"17","author":"Eldred-Evans","year":"2020","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.euo.2026.03.014_b0025","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.euo.2020.12.004","article-title":"Positive predictive value of Prostate Imaging Reporting and Data System version 2 for the detection of clinically significant prostate cancer: a systematic review and meta-analysis","volume":"4","author":"Mazzone","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2026.03.014_b0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.eururo.2017.01.042","article-title":"Diagnostic performance of Prostate Imaging Reporting and Data System version 2 for detection of prostate cancer: a systematic review and diagnostic meta-analysis","volume":"72","author":"Woo","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.03.014_b0035","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.juro.2016.01.114","article-title":"A pilot study to evaluate the role of magnetic resonance imaging for prostate cancer screening in the general population","volume":"196","author":"Nam","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2026.03.014_b0040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.euros.2020.07.003","article-title":"Confirmation by early oncologic outcomes after surgery of the accuracy of intermediate-risk prostate cancer classification based on magnetic resonance imaging staging and targeted biopsy","volume":"21","author":"Manceau","year":"2020","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.euo.2026.03.014_b0045","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.juro.2018.06.041","article-title":"Multiparametric magnetic resonance imaging features identify aggressive prostate cancer at the phenotypic and transcriptomic level","volume":"200","author":"Beksac","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2026.03.014_b0050","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.eururo.2019.09.005","volume":"77","author":"Gandaglia","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.03.014_b0055","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.eururo.2018.05.035","article-title":"Prostate Imaging-reporting and Data System steering committee: PI-RADS v2 status update and future directions","volume":"75","author":"Padhani","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.03.014_b0060","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/21681805.2021.1881612","article-title":"The G\u00d6TEBORG prostate cancer screening 2 trial: a prospective, randomised, population-based prostate cancer screening trial with prostate-specific antigen testing followed by magnetic resonance imaging of the prostate","volume":"55","author":"Kohestani","year":"2021","journal-title":"Scand J Urol"},{"key":"10.1016\/j.euo.2026.03.014_b0065","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1001\/jama.2024.3841","article-title":"Prostate cancer screening with PSA, kallikrein panel, and MRI: the ProScreen randomized trial","volume":"331","author":"Auvinen","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.euo.2026.03.014_b0070","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S1470-2045(21)00348-X","article-title":"Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial","volume":"22","author":"Nordstr\u00f6m","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euo.2026.03.014_b0075","doi-asserted-by":"crossref","first-page":"E171","DOI":"10.1111\/j.1464-410X.2011.10112.x","article-title":"Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection","volume":"108","author":"Haffner","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2026.03.014_b0080","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.eururo.2018.03.007","article-title":"Negative multiparametric magnetic resonance imaging for prostate cancer: what\u2019s next?","volume":"74","author":"Panebianco","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.03.014_b0085","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1158\/1055-9965.EPI-23-1208","article-title":"Risk of clinically significant prostate cancer after a nonsuspicious prostate MRI-A comparison with the general population","volume":"33","author":"Pylv\u00e4l\u00e4inen","year":"2024","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.euo.2026.03.014_b0090","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.prnil.2020.06.001","article-title":"The significance of the visible tumor on preoperative magnetic resonance imaging in localized prostate cancer","volume":"9","author":"Shin","year":"2021","journal-title":"Prostate Int"},{"key":"10.1016\/j.euo.2026.03.014_b0095","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.eururo.2015.01.013","article-title":"Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature","volume":"68","author":"F\u00fctterer","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.03.014_b0100","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/JU.0000000000004069","article-title":"The genomics and natural history of MRI-visible vs MRI-invisible prostate cancers: clinical implications","volume":"212","author":"Klotz","year":"2024","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2026.03.014_b0105","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/ijc.34743","article-title":"Histomic and transcriptomic features of MRI-visible and invisible clinically significant prostate cancers are associated with prognosis","volume":"154","author":"Lehto","year":"2024","journal-title":"Int J Cancer"},{"key":"10.1016\/j.euo.2026.03.014_b0110","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00345-023-04371-6","article-title":"Prognostic significance of PI-RADS 5 lesions in patients treated by radical prostatectomy","volume":"41","author":"Fiard","year":"2023","journal-title":"World J Urol"},{"key":"10.1016\/j.euo.2026.03.014_b0115","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.clgc.2022.04.001","article-title":"MRI-detectability of clinically significant prostate cancer relates to oncologic outcomes after prostatectomy","volume":"20","author":"Wibmer","year":"2022","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.euo.2026.03.014_b0120","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1007\/s00261-021-03249-8","article-title":"Results from a PI-RADS-based MRI-directed diagnostic pathway for biopsy-naive patients in a non-university hospital","volume":"46","author":"Reijnen","year":"2021","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.euo.2026.03.014_b0125","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.euo.2020.11.008","article-title":"Association between multiparametric magnetic resonance imaging of the prostate and oncological outcomes after primary treatment for prostate cancer: a systematic review and meta-analysis","volume":"4","author":"Stabile","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2026.03.014_b0130","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/JU.0000000000001821","article-title":"The prognostic association of prostate MRI PI-RADS\u2122 v2 assessment category and risk of biochemical recurrence after definitive local therapy for prostate cancer: a systematic review and meta-analysis","volume":"206","author":"Rajwa","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2026.03.014_b0135","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3348\/kjr.2018.0613","article-title":"Prognostic significance for long-term outcomes following radical prostatectomy in men with prostate cancer: evaluation with Prostate Imaging Reporting and Data System version 2","volume":"20","author":"Kim","year":"2019","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.euo.2026.03.014_b0140","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1158\/1538-7445.AM2022-2234","article-title":"Incidence of clinically significant prostate cancer after negative prostate MRI - comparison to general population","volume":"82","author":"Pylv\u00e4l\u00e4inen","year":"2022","journal-title":"Cancer Res"},{"key":"10.1016\/j.euo.2026.03.014_b0145","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1097\/JU.0000000000001474","article-title":"Oncologic outcomes after localized prostate cancer treatment: associations with pretreatment prostate magnetic resonance imaging findings","volume":"205","author":"Wibmer","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2026.03.014_b0150","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/ijc.23126","article-title":"Assessment of causes of death in a prostate cancer screening trial","volume":"122","author":"M\u00e4kinen","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.euo.2026.03.014_b0155","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.euros.2022.04.011","article-title":"Risk estimation of metastatic recurrence after prostatectomy: A model using preoperative magnetic resonance imaging and targeted biopsy","volume":"41","author":"Bommelaere","year":"2022","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.euo.2026.03.014_b0160","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2214122","article-title":"Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"388","author":"Hamdy","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euo.2026.03.014_b0165","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.euo.2025.01.008","article-title":"Are patients with Prostate Imaging Reporting and Data System 5 lesions eligible for active surveillance? A multicentric European study","volume":"8","author":"Peyrottes","year":"2025","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2026.03.014_b0170","unstructured":"Memorial Sloan Kettering Cancer Center. Dynamic prostate cancer nomogram: coefficients [Internet], http:\/\/www.mskcc.org\/nomograms\/prostate\/pre_op\/coefficients; (accessed 6 February 2026)."},{"key":"10.1016\/j.euo.2026.03.014_b0175","doi-asserted-by":"crossref","first-page":"5039","DOI":"10.1002\/cncr.26169","article-title":"The CAPRA-S score: a straightforward tool for improved prediction of outcomes after radical prostatectomy","volume":"117","author":"Cooperberg","year":"2011","journal-title":"Cancer"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931126000738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931126000738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T21:19:38Z","timestamp":1778188778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931126000738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":35,"alternative-id":["S2588931126000738"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2026.03.014","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PI-RADS v2 and Adverse Prostate Cancer Outcomes: A Cross-cohort Replication Study Across Three Centers","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2026.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}